DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

References

Slamon DJ, Eiermann W, Robert NJ. et al. On Behalf of the BCIRG-006 Investigators.
Ten year follow-up of BCIRG-006 comparing doxorubicin plus cyclophosphamide followed by docetaxel (AC→T) with doxorubicin plus cyclophosphamide followed by docetaxel and trastuzumab (AC→TH) with docetaxel, carboplatin and trastuzumab (TCH) in HER2+ early breast cancer.

Cancer Res 2016;
76 (4 Suppl.) Abstract nr. S5-04
DOI: 10.1158/1538-7445.SABCS15-S5-04.

Download Bibliographical Data

Search in:
Access: